A citation-based method for searching scientific literature

John B Buse, Deborah J Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A D'Alessio, Melanie J Davies. Diabetes Care 2020
Times Cited: 348



Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn, William M Steinberg, Mette Stockner, Bernard Zinman, Richard M Bergenstal, John B Buse. N Engl J Med 2016
Times Cited: 3031




List of shared articles



Times cited

Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Diabetology.
Paul Valensi, Patrick Henry, Franck Boccara, Emmanuel Cosson, Gaetan Prevost, Joseph Emmerich, Laura Ernande, Dany Marcadet, Elie Mousseaux, François Rouzet,[...]. Diabetes Metab 2021
5


GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.
Michael A Nauck, Daniel R Quast, Jakob Wefers, Juris J Meier. Mol Metab 2021
37


Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics.
Manfred Hecking, Adnan Sharif, Kathrin Eller, Trond Jenssen. Transpl Int 2021
6


Guideline recommendations and the positioning of newer drugs in type 2 diabetes care.
Nikolaus Marx, Melanie J Davies, Peter J Grant, Chantal Mathieu, John R Petrie, Francesco Cosentino, John B Buse. Lancet Diabetes Endocrinol 2021
22

Monitoring and management of hyperglycemia in patients with advanced diabetic kidney disease.
Gustavo Monteiro Escott, Letícia Guimarães da Silveira, Vitor da Agostim Cancelier, Angélica Dall'Agnol, Sandra Pinho Silveiro. J Diabetes Complications 2021
0

Novel management of diabetes in kidney transplantation.
Song C Ong, Connie M Rhee. Curr Opin Nephrol Hypertens 2021
3

Practical Considerations and Rationale for Glucagon-Like Peptide-1 Receptor Agonist Plus Sodium-Dependent Glucose Cotransporter-2 Inhibitor Combination Therapy in Type 2 Diabetes.
Ronald M Goldenberg, Vineeta Ahooja, Kristin K Clemens, Jeremy D Gilbert, Megha Poddar, Subodh Verma. Can J Diabetes 2021
1

Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.
Giulia Ferrannini, Hertzel Gerstein, Helen Martina Colhoun, Gilles R Dagenais, Rafael Diaz, Leanne Dyal, Mark Lakshmanan, Linda Mellbin, Jeffrey Probstfield, Matthew Casey Riddle,[...]. Eur Heart J 2021
4

Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence.
Radica Z Alicic, Emily J Cox, Joshua J Neumiller, Katherine R Tuttle. Nat Rev Nephrol 2021
15

Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Diabetology.
Paul Valensi, Patrick Henry, Franck Boccara, Emmanuel Cosson, Gaetan Prevost, Joseph Emmerich, Laura Ernande, Dany Marcadet, Elie Mousseaux, François Rouzet,[...]. Arch Cardiovasc Dis 2021
1

Latin American Expert Consensus for Comprehensive Management of Type 2 Diabetes from a Metabolic-Cardio-Renal Perspective for the Primary Care Physician.
Roopa Mehta, Daniel Pichel, Chih Hao Chen-Ku, Pablo Raffaele, Antonio Méndez Durán, Francisco Padilla, Jose Javier Arango Alvarez, José Esteban Costa Gil, Juan Esteban Gómez Mesa, Mariano Giorgi,[...]. Diabetes Ther 2021
0


Should metformin remain the first-line therapy for treatment of type 2 diabetes?
Chelsea Baker, Cimmaron Retzik-Stahr, Vatsala Singh, Renee Plomondon, Victoria Anderson, Neda Rasouli. Ther Adv Endocrinol Metab 2021
4

Comparative Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults.
Elisabetta Patorno, Ajinkya Pawar, Lily G Bessette, Dae H Kim, Chintan Dave, Robert J Glynn, Medha N Munshi, Sebastian Schneeweiss, Deborah J Wexler, Seoyoung C Kim. Diabetes Care 2021
6

Prescribing in Type 2 Diabetes Patients With and Without Cardiovascular Disease History: A Descriptive Analysis in the UK CPRD.
Ruth E Farmer, Ivan Beard, Syed I Raza, Nicholas D Gollop, Niraj Patel, Abigail Tebboth, Andrew P McGovern, Naresh Kanumilli, Andrew Ternouth. Clin Ther 2021
2

Trends in diabetes medication use in Australia, Canada, England, and Scotland: a repeated cross-sectional analysis in primary care.
Michelle Greiver, Alys Havard, Juliana Kf Bowles, Sumeet Kalia, Tao Chen, Babak Aliarzadeh, Rahim Moineddin, Julian Sherlock, William Hinton, Frank Sullivan,[...]. Br J Gen Pract 2021
1



Oral Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses.
Richard E Pratley, Matthew J Crowley, Mette Gislum, Christin L Hertz, Thomas B Jensen, Kamlesh Khunti, Ofri Mosenzon, John B Buse. Diabetes Ther 2021
1

GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis.
Thomas Karagiannis, Apostolos Tsapas, Eleni Athanasiadou, Ioannis Avgerinos, Aris Liakos, David R Matthews, Eleni Bekiari. Diabetes Res Clin Pract 2021
4


The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk.
Cyrielle Caussy, Adrien Aubin, Rohit Loomba. Curr Diab Rep 2021
2

Report from the CVOT Summit 2020: new cardiovascular and renal outcomes.
Oliver Schnell, Xavier Cos, Francesco Cosentino, Thomas Forst, Francesco Giorgino, Hiddo J L Heersprink, Mikhail Kosiborod, Christoph Wanner, Eberhard Standl. Cardiovasc Diabetol 2021
1

Treating Arterial Ageing in Patients with Diabetes: From Mechanisms to Effective Drugs.
Mojca Lunder, Miodrag Janić, Mišo Šabovič. Int J Mol Sci 2021
1